2 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow Prematurity: new trials by email Literature Review of Prematurity trials Research Report on Prematurity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress Caffeine citrate, Placebo - Prematurity, Respiratory Disease | Phase 2 / Phase 3 | Recruiting | Ministry of Health, Saudi Arabia | 134 | 2023-10-12 | 2025-06-27 |
| Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants Darbepoetin Alfa, Low Molecular Weight Iron Dextran, Ferumoxytol injection - Prematurity, Iron-deficiency | Phase 2 | Recruiting | University of Washington | 120 | 2022-11-27 | 2026-05-26 |
Premature Birth (2) · Anemia (1) · Anemia, Iron-Deficiency (1) · Bronchopulmonary Dysplasia (1) · Iron Deficiencies (1) · Respiration Disorders (1)
Female Urogenital Diseases and Pregnancy Complications (2) · Obstetric Labor Complications (2) · Obstetric Labor, Premature (2) · Pregnancy Complications (2) · Urogenital Diseases (2) · Anemia, Hypochromic (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Infant, Newborn, Diseases (1) · Infant, Premature, Diseases (1) · Iron Metabolism Disorders (1) · Lung Diseases (1) · Lung Injury (1) · Metabolic Diseases (1)
Darbepoetin alfa (1) · Ferrosoferric Oxide (1) · Iron-Dextran Complex (1) · Sodium Chloride (1) · caffeine citrate (1)
Ministry of Health, Saudi Arabia (1) · University of Washington (1)
Saudi Arabia (1) · United States (1)
Kendell R German, MD (1) · Nehad Nasef (1)
R01HD107003 (1)